Skip To Main Content
Paul Hahn on Muck Rack

Paul Hahn

As seen in: Nature, arXiv, Healio, OSLI Retina, HCP Live, American Journal of Managed Care, Ophthalmology Times Europe, Retinal Physician, Optometry Times, EyeTube and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Paul

Contact Paul, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Computer Science > Machine Learning

|
By Paul Hahn, Marek Herde, Christoph Sandrock
| arXiv
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website. Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them. Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Open in Who Shared View Duplicates (650) Issue with article?

Episode 23: Pegcetacoplan Versus Avacincaptad Pegol

|
By Nitish Mehta, Paul Hahn
| EyeTube
Episode 23: Pegcetacoplan Versus Avacincaptad Pegol Nitish Mehta, MD, and Paul Hahn, MD, PhD, FASRS Show Description + Nitish Mehta, MD, invites Paul Hahn, MD, PhD, FASRS, to discuss his recent study evaluating the efficacy of intravitreal pegcetacoplan versus avacincaptad pegol in patients with geographic atrophy.
Open in Who Shared Issue with article?

AREDS Micronutrients Show No Benefit in Geographic Atrophy, with Paul Hahn, MD, PhD

|
By Paul Hahn
| consultantlive.com
AREDS micronutrients exhibited no benefit on geographic atrophy (GA) progression towards the fovea nor overall GA growth in a recent sham-controlled, randomized prospective phase 3 study presented at the 43rd Annual Scientific Meeting of the American Society of Retina Specialists in Long Beach, CA.1 Micronutrient supplementation has been a divisive topic in ophthalmology since the Age-Related Eye Diseases Study (AREDS) and AREDS2.
Open in Who Shared View Duplicates (2) Issue with article?
See all 19 licensed articles (34 Total)